Andrew Zappia, leader of Troutman Pepper Locke’s Health Care and Life Sciences Industry Group, was quoted in the March 9, 2026 Managing IP article, “IP Leaders: How To Survive ‘Merger Mania’.”

  • Similarly, Andrew Zappia, partner at Troutman Pepper Locke, notes that the merger was driven by common culture and values, along with geographic and practice synergies.
  • Zappia says that the IP practice under the merged firm has seen an increase in new business.
  • “We have seen a very significant increase in new IP matters (prosecution, post-issuance, and litigation) from biotech and brand pharma clients as a direct result of the added capabilities from the merger.”
Insight Industries + Practices